Report Detail
Transmucosal Drug Delivery Market By Delivery Route ( Buccal cavity, Nasal cavity, Vagina ), By Drug Type ( Buccal tablets, Oral sprays, Sublingual films and wafers, Gels ), Industry Trends, Estimation & Forecast, 2017 - 2025
- RnM3857941 |
- 23 December, 2019 |
- Global |
- 145 Pages |
- Esticast Research & Consulting |
- Pharma & Healthcare
The research report offers a comprehensive picture of the Transmucosal Drug Delivery market. The report initiates with the executive summary of the market that includes market definition, recent industry trends, and developments, strategies of the key players and wide product offerings. Moreover, the study explains the future opportunities and a sketch of the key participants actively operating in the market.
About Transmucosal Drug Delivery Market
Advancements and continuous research in the delivery systems for drug in humans has paved the way for transmucosal drug delivery market in the recent years. It is a lucrative market with numerous opportunities for the players involved in its value chain. Transmucosal drug delivery is gaining high adoption as compared to the other drug delivery systems, as it allows drugs to avoid the natural defense mechanism of the body. Most of the prescribed drugs when administered via other delivery routes become ineffective due to the body’s defense mechanisms such as harsh gastrointestinal environment and first pass liver metabolism. The transmucosal route mainly includes the buccal, nasal, and vaginal cavities that have a permeable membrane with a rich blood flow. The mucous membranes that are mainly present in the mouth and nose have 4-400 times higher permeability than the epidermal membranes, and thus act as an effective drug delivery system.
The research report is prepared based on the combination of qualitative as well as quantitative aspects. By thorough understanding, the report is fragmented by larger ratios. The report covers in-depth analysis with major factors such as drivers, restraints, opportunities, and challenges that influences the growth of the market. On the other hand, The Transmucosal Drug Delivery report presents data starting from the base year 2018, historical year: 2014-2018, estimated the year 2019 and Forecast year from 2019 to 2026.
The Transmucosal Drug Delivery market report offers the market size and estimates the forecast from 2019-2026. The forecast estimation is predicted based on the key regions that include North America, Europe, Asia Pacific, Middle East, South America, and the Middle East & Africa. Furthermore, the Transmucosal Drug Delivery report provides a deep emphasis on secondary tools used to document the report. PEST analysis, SWOT, Porter’s Five Forces, and others are considered by the analysts while preparing the report.
Scope and Segmentation of the Market
Based on Type
By Drug type
Buccal tablets
Oral sprays
Sublingual films and wafers
Gels
Others (medicated confectionery)
Based on Application
Application 1
Application 2
Each segment of the Transmucosal Drug Delivery market is extensively evaluated in the research study. The segment analysis covered in the report aims at the key opportunities available in the Transmucosal Drug Delivery market report by leading segments. In addition, the research report offers market dynamics for the market that influences qualitative as well as quantitative research.
Research Methodology
The report follows a comprehensive and rigorous research methodology to provide you accurate estimates and forecasts of a particular market. The report provide estimates, forecast, and analysis primarily based on secondary research, primary interviews, in-house database and other free as well as paid sources. In addition, the research methodology we follow is a systematic approach in order to estimate and project the market sizing keeping in mind all the ongoing and upcoming trends of the market.
Competitive Landscape
Key players profiled in this report include (Sales Revenue, Price, Gross Margin, Main Products, etc.):
DURECT Corporation
Pantec Biosolutions AG
Acrux Limited
Mylan
Inc.
ALZA Corporation
Antares Pharma
Inc.
Noven Pharmaceuticals
Inc.
3M Pharmaceuticals
Apricus BioSciences
Inc
Corium International
Inc
TEVA Pharmaceutical Industries Ltd.
Generex Biotechnology Corporation
Aveva Drug Delivery Systems
MedPharm LTD
Zosano Pharma
Nitto Denko Corporation
Tapemark
Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)
tesa Labtec GmbH
Inovio Pharmaceuticals
Inc.
Nemaura Pharma Ltd
Through the successive chapters on the company, profiles provide deep insights on players operating in the Transmucosal Drug Delivery market. It focuses on the financial outlook of the key players, the status of R&D, strategies adopted, expansion strategies, and many more. Analysts preparing the report have offered a detailed list of the strategic initiatives adopted by the Transmucosal Drug Delivery market participants by referring past records and designing strategies to be adopted in the coming years. This enables the key players to stay ahead in the competition.
Regional Landscape
The chapter on regional segmentation details the regional aspects of the Transmucosal Drug Delivery market. This chapter explains the regulatory framework that is likely to impact the overall market. It highlights the political scenario in the market and anticipates its influence on the Transmucosal Drug Delivery market. Moreover, the report focuses on value and volume at the regional level, company level, and level.
Chapters covered under this report include:
Chapter 1, describes the Transmucosal Drug Delivery market reports - market overview, executive summary, and market scope. Further, the report adds a support base to identify the information and pick in relation to the aforementioned market
Chapter 2, defines the research methodology based on primary as well as secondary research, secondary data sources, and assumptions & exclusions
Chapter 3, description of Transmucosal Drug Delivery market in terms of its product scope, opportunities, drivers, restraints, and market risks
Chapter 4, the report offers a company profile of the top manufacturers of Transmucosal Drug Delivery market with its sales, revenue, share, and others
Chapter 5 and 6, to narrow down the sales data at the country level with shares, revenue, sand sales from 2018-2026
Chapter 7, the Transmucosal Drug Delivery market data is published based on a regional level and to show the revenue, sales, and growth on basis of the base year 2018, historical year: 2014-2018, estimated the year 2019 and Forecast year from 2019 to 2026
Chapter 8, describes the Transmucosal Drug Delivery market sales channels, distributors, research findings, appendix, and among others.
CHAPTER 1. INTRODUCTION
- 1.1. RESEARCH METHODOLOGY
- 1.1.1. ERC desk research
- 1.1.2. ERC data synthesis
- 1.1.3. Data validation and market feedback
- 1.1.4. ERC data sources
CHAPTER 2. TRANSMUCOSAL DRUG DELIVERY MARKET OVERVIEW
- 2.1. TRANSMUCOSAL DRUG DELIVERY MARKET INTRODUCTION
- 2.2. GLOBAL TRANSMUCOSAL DRUG DELIVERY MARKET PRODUCTION AND GROWTH RATE, 2017-2025
- 2.2.1. Global Transmucosal Drug Delivery Production (VOLUME) and Growth Rate (%), (2017-2025)
- 2.3. GLOBAL TRANSMUCOSAL DRUG DELIVERY MARKET CAPACITY AND GROWTH RATE, 2017-2025
- 2.3.1. Global Transmucosal Drug Delivery Capacity (VOLUME) and Growth Rate (%), (2017-2025)
- 2.4. GLOBAL TRANSMUCOSAL DRUG DELIVERY MARKET REVENUE AND GROWTH RATE, 2017-2025
- 2.4.1. Global Transmucosal Drug Delivery Market Revenue (Million USD) and Growth Rate (%), (2017-2025)
- 2.5. GLOBAL TRANSMUCOSAL DRUG DELIVERY MARKET CONSUMPTION AND GROWTH RATE, 2017-2025
- 2.5.1. Global Transmucosal Drug Delivery Consumption (VOLUME) and Growth Rate (%), (2017-2025)
- 2.6. GLOBAL TRANSMUCOSAL DRUG DELIVERY MARKET PRICE TREND, 2017-2025
- 2.6.1. Global Transmucosal Drug Delivery Market Price Trend and Growth Rate (%), (2017-2025)
CHAPTER 3. GLOBAL TRANSMUCOSAL DRUG DELIVERY MARKET BY DRUG TYPE, 2017-2025
- 3.1. BUCCAL TABLETS
- 3.2. ORAL SPRAYS
- 3.3. SUBLINGUAL FILMS AND WAFERS
- 3.4. GLOBAL TRANSMUCOSAL DRUG DELIVERY MARKET REVENUE BY DRUG TYPE, 2017-2025
- 3.4.1. Global Transmucosal Drug Delivery Market Revenue (Million USD) and Share (%) By Drug type, 2017-2025
- 3.4.2. Buccal tablets Market Revenue and Growth Rate, 2017-2025
- 3.4.3. Oral sprays Market Revenue and Growth Rate, 2017-2025
- 3.4.4. Sublingual films and wafers Market Revenue and Growth Rate, 2017-2025
- 3.5. GLOBAL TRANSMUCOSAL DRUG DELIVERY MARKET PRODUCTION BY DRUG TYPE, 2017-2025
- 3.5.1. Global Transmucosal Drug Delivery Market Production (Volume) and Share (%) By Drug type, 2017-2025
- 3.5.2. Buccal tablets Market Production and Growth Rate, 2017-2025
- 3.5.3. Oral sprays Market Production and Growth Rate, 2017-2025
- 3.5.4. Sublingual films and wafers Market Production and Growth Rate, 2017-2025
Note: Similar information coverage has been provided for other drug type segment.
CHAPTER 4. GLOBAL TRANSMUCOSAL DRUG DELIVERY MARKET BY DELIVERY ROUTE, 2017-2025
- 4.1. BUCCAL CAVITY
- 4.2. NASAL CAVITY
- 4.3. VAGINA
- 4.4. GLOBAL TRANSMUCOSAL DRUG DELIVERY MARKET REVENUE BY DELIVERY ROUTE, 2017-2025
- 4.4.1. Global Transmucosal Drug Delivery Market Revenue (Million USD) and Share (%) By Delivery route, 2017-2025
- 4.4.2. Buccal cavity Market Revenue and Growth Rate, 2017-2025
- 4.4.3. Nasal cavity Market Revenue and Growth Rate, 2017-2025
- 4.4.4. Vagina Market Revenue and Growth Rate, 2017-2025
- 4.5. GLOBAL TRANSMUCOSAL DRUG DELIVERY MARKET CONSUMPTION BY DELIVERY ROUTE, 2017-2025
- 4.5.1. Global Transmucosal Drug Delivery Market Consumption (Volume) and share (%) By Delivery route, 2017-2025
- 4.5.2. Buccal cavity Market Consumption and Growth Rate, 2017-2025
- 4.5.3. Nasal cavity Market Consumption and Growth Rate, 2017-2025
- 4.5.4. Vagina Market Consumption and Growth Rate, 2017-2025
Note: Similar information coverage has been provided for other delivery route segment.
CHAPTER 5. GLOBAL TRANSMUCOSAL DRUG DELIVERY MARKET BY REGION, 2017-2025
- 5.1. NORTH AMERICA
- 5.1.1. U.S.
- 5.1.2. Canada
- 5.1.3. Mexico
- 5.2. EUROPE
- 5.2.1. U.K.
- 5.2.2. France
- 5.2.3. Germany
- 5.2.4. Italy
- 5.2.5. Spain
- 5.2.6. Rest of Europe
- 5.3. ASIA PACIFIC
- 5.3.1. China
- 5.3.2. Japan
- 5.3.3. India
- 5.3.4. Korea
- 5.3.5. Rest of APAC
- 5.4. SOUTH AMERICA
- 5.4.1. Brazil 31
- 5.4.2. Rest of South America
- 5.5. REST OF THE WORLD
- 5.5.1. Middle East
- 5.5.2. Africa
- 5.6. GLOBAL TRANSMUCOSAL DRUG DELIVERY MARKET REVENUE BY REGION, 2017-2025
- 5.6.1. Global Transmucosal Drug Delivery Market Revenue (Million USD) and Share (%) By Region, 2017-2025
- 5.6.2. North America Market Revenue and Growth Rate, 2017-2025
- 5.6.3. Europe Market Revenue and Growth Rate, 2017-2025
- 5.6.4. Asia Pacific Market Revenue and Growth Rate, 2017-2025
- 5.6.5. South America Market Revenue and Growth Rate, 2017-2025
- 5.6.6. Rest of the World Market Revenue and Growth Rate, 2017-2025
CHAPTER 6. GLOBAL TRANSMUCOSAL DRUG DELIVERY MARKET PRODUCTION AND CONSUMPTION ANALYSIS BY REGION, 2017-2025
- 6.1. GLOBAL TRANSMUCOSAL DRUG DELIVERY MARKET PRODUCTION ANALYSIS BY REGION, 2017-2025
- 6.1.1. Global Transmucosal Drug Delivery Market Production (Volume) and Share (%) By Region, 2017-2025
- 6.1.2. Global Transmucosal Drug Delivery Market Consumption (Volume) and Share (%) By Region, 2017-2025
- 6.1.3. North America Market Production and Consumption, 2017-2025
- 6.1.4. Europe Market Production and Consumption, 2017-2025
- 6.1.5. Asia Pacific Market Production and Consumption, 2017-2025
- 6.1.6. South America Market Production and Consumption, 2017-2025
- 6.1.7. Rest of the World Market Production and Consumption, 2017-2025
CHAPTER 7. MARKET DETERMINANTS
- 7.1. MARKET DRIVERS
- 7.2. MARKET RESTRAINTS
- 7.3. MARKET OPPORTUNITIES
- 7.4. MARKET DETERMINANTS RADAR CHART
CHAPTER 8. GLOBAL TRANSMUCOSAL DRUG DELIVERY MARKET COMPETITION BY MANUFACTURERS
- 8.1. GLOBAL TRANSMUCOSAL DRUG DELIVERY PRODUCTION AND SHARE BY MANUFACTURERS (2017-2025)
- 8.1.1. Global Transmucosal Drug Delivery Production (VOLUME) and Share (%) by Manufacturers (2017-2025)
- 8.2. GLOBAL TRANSMUCOSAL DRUG DELIVERY REVENUE AND SHARE BY MANUFACTURERS (2017-2025)
- 8.2.1. Global Transmucosal Drug Delivery Revenue (Million USD) and Share (%) by Manufacturers (2017-2025)
- 8.3. TRANSMUCOSAL DRUG DELIVERY MARKET COMPETITIVE SITUATION AND TRENDS
- 8.3.1. Transmucosal Drug Delivery Market Share (%) of Top 3 Manufacturers
- 8.3.2. Transmucosal Drug Delivery Market Share (%) of Top 5 Manufacturers
CHAPTER 9. GLOBAL TRANSMUCOSAL DRUG DELIVERY MANUFACTURERS ANALYSIS
- 9.1. DURECT CORPORATION
- 9.1.1. Business Overview
- 9.1.2. Company Basic Information
- 9.1.3. Transmucosal Drug Delivery Product Details
- 9.1.4. DURECT Corporation Transmucosal Drug Delivery Production, Revenue and Gross Margin
- 9.2. PANTEC BIOSOLUTIONS AG
- 9.2.1. Business Overview
- 9.2.2. Company Basic Information
- 9.2.3. Transmucosal Drug Delivery Product Details
- 9.2.4. Pantec Biosolutions AG Transmucosal Drug Delivery Production, Revenue and Gross Margin
- 9.3. ACRUX LIMITED
- 9.3.1. Business Overview
- 9.3.2. Company Basic Information
- 9.3.3. Transmucosal Drug Delivery Product Details
- 9.3.4. Acrux Limited Transmucosal Drug Delivery Production, Revenue and Gross Margin
- 9.4. MYLAN, INC.
- 9.4.1. Business Overview
- 9.4.2. Company Basic Information
- 9.4.3. Transmucosal Drug Delivery Product Details
- 9.4.4. Mylan, Inc. Transmucosal Drug Delivery Production, Revenue and Gross Margin
- 9.5. ALZA CORPORATION
- 9.5.1. Business Overview
- 9.5.2. Company Basic Information
- 9.5.3. Transmucosal Drug Delivery Product Details
- 9.5.4. ALZA Corporation Transmucosal Drug Delivery Production, Revenue and Gross Margin
- 9.6. ANTARES PHARMA, INC.
- 9.6.1. Business Overview
- 9.6.2. Company Basic Information
- 9.6.3. Transmucosal Drug Delivery Product Details
- 9.6.4. Antares Pharma, Inc. Transmucosal Drug Delivery Production, Revenue and Gross Margin
- 9.7. NOVEN PHARMACEUTICALS, INC.
- 9.7.1. Business Overview
- 9.7.2. Company Basic Information
- 9.7.3. Transmucosal Drug Delivery Product Details
- 9.7.4. Noven Pharmaceuticals, Inc. Transmucosal Drug Delivery Production, Revenue and Gross Margin
- 9.8. 3M PHARMACEUTICALS
- 9.8.1. Business Overview
- 9.8.2. Company Basic Information
- 9.8.3. Transmucosal Drug Delivery Product Details
- 9.8.4. 3M Pharmaceuticals Transmucosal Drug Delivery Production, Revenue and Gross Margin
- 9.9. APRICUS BIOSCIENCES, INC
- 9.9.1. Business Overview
- 9.9.2. Company Basic Information
- 9.9.3. Transmucosal Drug Delivery Product Details
- 9.9.4. Apricus BioSciences, Inc Transmucosal Drug Delivery Production, Revenue and Gross Margin
- 9.10. CORIUM INTERNATIONAL, INC
- 9.10.1. Business Overview
- 9.10.2. Company Basic Information
- 9.10.3. Transmucosal Drug Delivery Product Details
- 9.10.4. Corium International, Inc Transmucosal Drug Delivery Production, Revenue and Gross Margin
CHAPTER 10. TRANSMUCOSAL DRUG DELIVERY MARKET VALUE CHAIN ANALYSIS
- 10.1. TRANSMUCOSAL DRUG DELIVERY INDUSTRIAL CHAIN ANALYSIS
- 10.2. TRANSMUCOSAL DRUG DELIVERY KEY RAW MATERIALS ANALYSIS
- 10.2.1. Key Raw Materials
- 10.2.2. Price Trend of Key Raw Materials
- 10.2.3. Key Suppliers of Raw Materials
- 10.3. MARKETING CHANNEL
- 10.3.1. Direct Marketing
- 10.3.2. Indirect Marketing
- 10.3.3. Distributors/Traders
- 10.4. CONSUMER ANALYSIS
- 10.4.1. Consumer 1
- 10.4.2. Consumer 2
- 10.4.3. Consumer 3
Summary:
Get latest Market Research Reports on Transmucosal Drug Delivery . Industry analysis & Market Report on Transmucosal Drug Delivery is a syndicated market report, published as Transmucosal Drug Delivery Market By Delivery Route ( Buccal cavity, Nasal cavity, Vagina ), By Drug Type ( Buccal tablets, Oral sprays, Sublingual films and wafers, Gels ), Industry Trends, Estimation & Forecast, 2017 - 2025. It is complete Research Study and Industry Analysis of Transmucosal Drug Delivery market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
